Pharma & Bio
Technology
Jeong Do-hyun, CEO of Raphas Co., Ltd.: “Allergy Drug in Efficacy Validation Phase… Technology Transfer Possible Even with Phase 1 Results”
“The most challenging stage in the development of microneedle-based pharmaceuticals is demonstrating clinical efficacy. Since Raphas Co., Ltd. has largely secured its production technology infrastruct…
Lifestyle
Dop Signs Consecutive LOIs with Global Organization Bank... 'Global Full-Chain Business Model' Officially Launched
DOP, a company specializing in decellularized human tissue, is accelerating its expansion into the global market by signing a series of Letters of Intent (LOIs) with global tissue banks, leveraging it…
Lifestyle
'World's Only' Ring-Type Blood Pressure Monitor... Will SkyLabs Become the Next SEERS?
SkyLabs, which is pursuing a KOSDAQ listing, is drawing attention for its steep sales growth even before going public. Although numerous domestic and international companies have attempted to develop …
Technology
Biotech Stocks Rally Despite Setbacks at Peptron and HLB [K-Bio Pulse]
Peptron and HLB Group companies plunged to their daily lower limits on July 10 amid separate setbacks. Despite the sharp sell-offs, buying momentum spread across the broader KOSDAQ market, lifting man…
Business·Industry
Despite the Peptron, Inc. and HLB INC. Shock, the Biotech Sector Remains Bullish… Warm Sentiment Spreads Across KOSDAQ [Biotech Spotlight]
On the 10th, in the biotech sector, Peptron, Inc.(087010)and #HLB INC. all hit their daily price limits due to individual negative factors. Nevertheless, buying momentum spread across the KOSDAQ marke…
Lifestyle
Hugel, Inc. Bought Time, Hans Bought a Sales Network... The Real Story Behind the Skinbooster Collaboration
Hugel, Inc. and HANS BIOMED CORPORATION have begun jointly marketing “CellREDM,” a human tissue-based skin booster. While this appears to be a distribution agreement on the surface, analysts view it a…
Technology
Peptron Plummets as Lilly Hopes Fade; Nature Cell and BL Pharmtech Hit Daily Limit-Up [K-Bio Pulse]
On July 9, South Korean pharmaceutical and biotech stocks saw sharply divergent movements, with Nature Cell and BL Pharmtech both hitting the daily upper limit, while Peptron tumbled to the lower limi…
Technology
Peptron, Inc. Hits After-Hours 'Lower Circuit' as Lilly Hopes Fade… NATURECELL CO.,LTD. and BL Pharmtech Rise [Bio Spotlight]
On the 9th, the domestic pharmaceutical and biotech stock market saw mixed results across individual stocks. While Peptron, Inc. hit the daily price limit down in after-hours trading, NATURECELL CO.,L…
Technology
'Generic Drug Inspection' Holds Up Ribozeranib… Even HLB INC. Was Unaware
It has been confirmed that the reason behind HLB INC.(028300)’s new liver cancer drug, Riboceranib, receiving its third Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) …
Business·Industry
Peptron, Inc. Emphasized "Smooth Sailing" with Lilly, but... Excluded from Joint Research After Mounjaro and MTA
Peptron, Inc.(087010), following its official statement that its joint research with Eli Lilly is proceeding normally, issued a revised notice around 12:00 p.m. today explaining that tirzepatide is in…